Alcami Expands Global Presence through Acquisition of Tjoapack

On April 21, 2026, Alcami Corporation, a well-recognized contract development and manufacturing organization (CDMO) based in the United States, announced a significant step in its growth journey through the acquisition of Tjoapack. This acquisition not only brings Tjoapack's extensive contract packaging expertise into Alcami’s portfolio but also marks Alcami’s inaugural venture into the European market.

Strategic Importance of the Acquisition

Alcami has been a key player in pharmaceutical development and manufacturing for over 45 years, and this consolidation with Tjoapack aims to strengthen its global CDMO platform. Tjoapack, a respected name in contract packaging for over 35 years, operates critical facilities in both the U.S. and The Netherlands. With this move, Alcami aims to enhance its supply chain redundancy options for pharmaceutical and biotech clients by integrating packaging and labeling services more efficiently.

Tjoapack has built a reputation around its capabilities in primary and secondary packaging solutions that include oral solid doses (like blisters and bottles) and sterile injectables (such as vials and pre-filled syringes). Their operational prowess, manifest in 23 fully equipped packaging lines and a workforce of over 400 skilled employees, supports over 40 commercial markets globally. This aligns perfectly with Alcami’s intention to offer comprehensive service solutions from a single provider as they aim to widen their global outreach.

Insights from Leadership

Patrick Walsh, Chairman and CEO of Alcami, emphasized the strategic relevance of this acquisition during the announcement. “This expansion into Europe is pivotal for our investment strategy. It enhances our capabilities while enabling us to provide our clients with a cohesive packaging and labeling service, alongside our existing offerings in testing and drug manufacturing,” he stated.

The acquisition will also give Alcami the opportunity to offer Qualified Person (QP) release and related services in Europe, making it easier for customers to ensure compliance with regulatory requirements in multiple markets. This seamless integration of service offerings is expected to greatly benefit Tjoapack’s existing clients, who will now have access to Alcami’s expanded range of services, including drug product manufacturing and Good Manufacturing Practice (GMP) pharmaceutical storage.

Dexter Tjoa, the CEO of Tjoapack, responded enthusiastically, indicating that the partnership would allow Tjoapack to capitalize on its strengths of quality, reliability, and customer focus, while accelerating growth opportunities. “Teaming up with Alcami allows us to leverage our respective strengths, creating a more integrated transatlantic platform that will greatly aid our partners in scaling their services globally,” remarked Tjoa.

Future Outlook

The deal is contingent on customary closing conditions and is projected to finalize in the upcoming second quarter of the year. This strategic alignment also indicates that Alcami is well-positioned to adapt to the evolving needs of the pharmaceutical industry, which increasingly demands an efficient, integrated approach to drug development and distribution.

As Alcami embarks on this new chapter with Tjoapack, the stakeholders are eager to see how this acquisition enhances their capability to provide rapid and comprehensive solutions to challenges faced by pharmaceutical companies.

About Alcami Corporation

Founded to advance pharmaceuticals from development to delivery, Alcami Corporation is headquartered in Wilmington, North Carolina. It offers a wide spectrum of integrated services including lab services, drug product manufacturing, and GMP storage, designed to meet the rigorous demands of today’s pharmaceutical landscape. Alcami’s ownership by private equity firms like GHO Capital and The Vistria Group reflects its commitment to growth and innovation in the biopharmaceutical sector.

About Tjoapack

Founded in 1989 and headquartered in The Netherlands, Tjoapack specializes in delivering high-quality contract packaging solutions vital to pharmaceutical and biotech industries. With its facilities in the U.S. and Europe, Tjoapack assures quality assurance in all its operations, underpinning its long-standing reputation in the market.

Through this acquisition, Alcami and Tjoapack are set to redefine their capabilities in the global pharmaceutical supply chain, strengthening their commitment to quality, compliance, and innovation in healthcare delivery.